Anti-diabetic treatment associated with reduced risk of developing blood cancer
People who use metformin are less likely to develop a myeloproliferative neoplasm (MPN) over time, indicating that the treatment may help prevent the development of certain types of cancers, according to a study published ...
14 hours ago
0
0
'Trojan Horse' weight loss drug found to be more effective than available therapies
In a study published in Nature, Christoffer Clemmensen and colleagues demonstrate a new use of the weight loss hormone GLP-1. GLP-1 can be used as a "Trojan Horse" to smuggle a specific molecule into the brain of mice, where ...
May 16, 2024
0
36
Examining the mechanisms and clinical potential of a promising non-opioid pain therapy candidate
A recent publication in Scientific Reports unveils a promising non-opioid pain treatment developed by a team led by Dr. Hernan Bazan, the John Ochsner Endowed Professor of Cardiovascular Innovation at Ochsner Health.
May 16, 2024
0
9
First US trial of varenicline for e-cigarette cessation shows positive results
The first U.S. trial of varenicline for e-cigarette cessation shows promising results and warrants larger-scale trials, the researchers say.
May 16, 2024
0
28
What is PrEP? Will it stop me getting HIV?
HIV prevention was allocated A$43.9 million over three years in this week's federal budget. Some $26m of this is for "PrEP" for people without access to Medicare.
May 16, 2024
0
0
Study finds taking cortisone with antacids can diminish bone density in rheumatism patients
Proton pump inhibitors (PPIs), a specific class of antacid drugs, are among the most widely used medications of all. They are frequently prescribed to many groups of patients, including those with rheumatism. PPIs are used ...
May 16, 2024
0
4
Study finds GLP-1 receptor agonist use increases likelihood of antidepressant prescription
Individuals taking glucagon-like peptide (GLP)-1 receptor agonists have a greater risk for subsequently being dispensed antidepressants, according to a study published online April 23 in Diabetes, Obesity, and Metabolism.
May 16, 2024
0
28
Novel inhibitor insights offer pathway to preventing PXR-associated drug resistance
Deaths from cancer or infections can occur when available treatments are ineffective. Once turned on, pregnane X receptor (PXR) activates the expression of genes encoding enzymes that metabolize external chemicals, including ...
May 15, 2024
0
58
Chiropractic associated with lower likelihood of tramadol prescription in adults with sciatica
A new study led by researchers at University Hospitals Connor Whole Health has found that adults initially receiving chiropractic spinal manipulation for newly diagnosed radicular low back pain (sciatica) were significantly ...
May 15, 2024
0
48
Exploring the mechanism behind drug eruptions in the skin
Although medications can often help patients find a cure or respite from their condition, millions of people worldwide suffer from unpredictable drug toxicities every year. In particular, drug eruptions which manifest through ...
May 15, 2024
0
16
New evidence for use of anti-inflammatory therapy for prevention of recurrent vascular events in stroke
In the international CONVINCE trial, presented today (15 May 2024) at the European Stroke Organization Conference (ESOC 2024), anti-inflammatory treatment with long-term colchicine did not reduce rates of recurrent stroke ...
May 15, 2024
0
0
Four in 10 adults with diabetes report taking a GLP-1 receptor agonist
One in eight adults (12 percent) say they have ever taken a glucagon-like peptide-1 receptor agonist (GLP-1 RA) and 6 percent say they are currently using one, according to the results of a new KFF Health Tracking Poll, released ...
May 15, 2024
0
6
Disparities seen in carbapenem-resistant Enterobacterales bloodstream infection outcomes
Black female patients hospitalized for carbapenem-resistant Enterobacterales (CRE) bloodstream infections (BSI) face increased 30-day mortality, according to a study presented at the annual European Society of Clinical Microbiology ...
May 15, 2024
0
0
Most slow responders to tirzepatide do lose clinically meaningful weight
Among slow responders to tirzepatide treatment at week 12, 90 percent went on to achieve clinically meaningful weight reduction (≥5 percent) by week 72, according to a study presented at the annual meeting of the American ...
May 15, 2024
0
0
Injectable HIV medication is superior to oral medication for patients who frequently miss doses, study finds
When a person is diagnosed with HIV, they are placed on a lifelong HIV treatment regimen, called antiretroviral therapy, to keep the virus under control. But for many people, having to take medicine every day can be a struggle ...
May 14, 2024
0
0
A new drug shows potential benefits in the recovery of patients after a heart attack
Researchers from the Cardiac Regeneration and Heart Failure Research Group (ICREC) at the Germans Trias i Pujol Research Institute (IGTP) and the Heart Institute of the Germans Trias Hospital (iCor) have found beneficial ...
May 14, 2024
0
0
Study reveals racial disparities in diagnosis and drug use for dementia symptoms
Compared to Black and Asian people, white and Hispanic people with Alzheimer's disease and related dementias were most likely to be diagnosed with symptoms like depression and agitation, according to a new study from the ...
May 14, 2024
0
0
Study finds some children were prescribed nonrecommended meds for COVID-19
Despite national guidelines, a small proportion of children were prescribed ineffective and potentially harmful medications for acute COVID-19, according to a study published online May 8 in Pediatrics.
May 14, 2024
0
0